FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' ...

GSK and AstraZeneca avoided the selloff on Thursday as pharmaceutical products were exempt from Donald’s Trump’s tariffs.

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

Donald Trump has repeatedly accused Pfizer of helping Joe Biden win the 2020 election - Francis Chung/Politico/Bloomberg ...

On the FTSE 350, Watches of Switzerland is down 15%, while Vietnam focused investment trusts VinaCapital Vietnam Opportunity ...